162 related articles for article (PubMed ID: 26883017)
1. C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
Cheang TY; Zhou HY; Chen W; Zhang B; Liu L; Yang J; Wang S; Li H
J Transl Med; 2016 Feb; 14():54. PubMed ID: 26883017
[TBL] [Abstract][Full Text] [Related]
2. C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.
Chen M; Ye Y; Zou B; Guo S; Zhou F; Lu K; Liu J; Xu Z; Han H; Liu Z; Li Y; Yao K; Liu C; Qin Z
J Transl Med; 2016 Feb; 14():55. PubMed ID: 26905879
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC.
Yang L; Li F; Lei F; Wang Y; Wu S; Song L; Chen Y
Tumour Biol; 2015 Sep; 36(10):7977-86. PubMed ID: 25964093
[TBL] [Abstract][Full Text] [Related]
4. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Zeng Z; Lin H; Zhao X; Liu G; Wang X; Xu R; Chen K; Li J; Song L
Clin Cancer Res; 2012 Aug; 18(15):4059-69. PubMed ID: 22675169
[TBL] [Abstract][Full Text] [Related]
8. Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.
Li X; Liang W; Liu J; Lin C; Wu S; Song L; Yuan Z
Breast Cancer Res; 2014 Oct; 16(5):465. PubMed ID: 25341494
[TBL] [Abstract][Full Text] [Related]
9. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
10. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
[TBL] [Abstract][Full Text] [Related]
11. C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
Chen J; Chen J; Gong Y; Zou B; Liu X; Ding L; Huang J; Zhang B; Li J
J Invest Surg; 2020 Dec; 33(10):914-923. PubMed ID: 30907217
[No Abstract] [Full Text] [Related]
12. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
13. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.
Jin Q; Mao X; Li B; Guan S; Yao F; Jin F
Tumour Biol; 2015 Mar; 36(3):1895-902. PubMed ID: 25377162
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
[TBL] [Abstract][Full Text] [Related]
17. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report.
You Y; Li H; Qin X; Zhang Y; Song W; Ran Y; Gao F
Cell Oncol (Dordr); 2015 Dec; 38(6):485-91. PubMed ID: 26392360
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
20. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
